Title |
Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
|
---|---|
Published in |
BMC Public Health, February 2015
|
DOI | 10.1186/s12889-015-1541-8 |
Pubmed ID | |
Authors |
Helena Rubinstein, Afrodita Marcu, Lucy Yardley, Susan Michie |
Abstract |
During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral medicines will help inform campaigns in future pandemic influenza outbreaks. Increasing uptake of vaccines and antiviral medicines may need to address a range of drivers of behaviour. The aim was to identify facilitators of and barriers to being vaccinated and taking antiviral medicines in uncertain and severe pandemic influenza scenarios using a theoretical model of behaviour change, COM-B. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 67% |
United States | 1 | 17% |
Unknown | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 33% |
Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Members of the public | 2 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Indonesia | 1 | <1% |
Unknown | 102 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 17% |
Student > Ph. D. Student | 16 | 15% |
Student > Master | 14 | 13% |
Student > Doctoral Student | 7 | 7% |
Student > Bachelor | 7 | 7% |
Other | 19 | 18% |
Unknown | 24 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 20% |
Psychology | 15 | 14% |
Nursing and Health Professions | 5 | 5% |
Agricultural and Biological Sciences | 5 | 5% |
Biochemistry, Genetics and Molecular Biology | 5 | 5% |
Other | 21 | 20% |
Unknown | 33 | 31% |